CXCR4 and skin basal cell carcinoma: Indeed, it has been demonstrated [34] that the addition of an ER-β receptor agonist to three different estrogen-responsive BCC lines, indirectly co-cultured with MG63, caused a decrease in their migration and in CXCR-4 expression.